NDC:
0121-2038-30
Unit Size/Quantity:
8 mg bottle (30 count)
Indication: Buprenorphine sublingual tablets is indicated for the treatment of opioid dependence and is preferred for induction.
Buprenorphine sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support.
Please see full Prescribing Information for more information.
Markings: White, round, biconvex uncoated tablets with “8” debossed on one side and a dart “→” debossed on the other side.
Storage and Handling: Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F).
